| FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
| 2. Issuer Name and Ticker or Trading Symbol Rapid7, Inc. [ RPD ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| ||||||||||||||||||||||||
| 3. Date of Earliest Transaction (Month/Day/Year) 07/22/2015 | ||||||||||||||||||||||||||
| 4. If Amendment, Date of Original Filed (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||||||||||||
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 07/22/2015 | C | 10,468 | A | (1) | 10,468 | I | TCV VII, L.P.(2)(3) | ||
| Common Stock | 07/22/2015 | C | 4,498,677 | A | (4) | 4,509,145 | I | TCV VII, L.P.(2)(3) | ||
| Common Stock | 07/22/2015 | C | 1,462,957(5) | A | (5) | 5,972,102 | I | TCV VII, L.P.(2)(3) | ||
| Common Stock | 07/22/2015 | P | 204,393 | A | $16 | 6,176,495 | I | TCV VII, L.P.(2)(3) | ||
| Common Stock | 07/22/2015 | C | 5,436 | A | (1) | 5,436 | I | TCV VII (A), L.P.(2)(6) | ||
| Common Stock | 07/22/2015 | C | 2,336,270 | A | (4) | 2,341,706 | I | TCV VII (A), L.P.(2)(6) | ||
| Common Stock | 07/22/2015 | C | 759,748(7) | A | (7) | 3,101,454 | I | TCV VII (A), L.P.(2)(6) | ||
| Common Stock | 07/22/2015 | P | 106,147 | A | $16 | 3,207,601 | I | TCV VII (A), L.P.(2)(6) | ||
| Common Stock | 07/22/2015 | C | 91 | A | (1) | 91 | I | TCV Member Fund, L.P.(2)(8) | ||
| Common Stock | 07/22/2015 | C | 38,850 | A | (4) | 38,941 | I | TCV Member Fund, L.P.(2)(8) | ||
| Common Stock | 07/22/2015 | C | 13,046(9) | A | (9) | 51,987 | I | TCV Member Fund, L.P.(2)(8) | ||
| Common Stock | 07/22/2015 | P | 1,960 | A | $16 | 53,947 | I | TCV Member Fund, L.P.(2)(8) | ||
| Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Series B Preferred Stock | (1) | 07/22/2015 | C | 10,468 | (1) | (1) | Common Stock | 10,468 | (1) | 0 | I | TCV VII, L.P.(2)(3) | |||
| Series B Preferred Stock | (1) | 07/22/2015 | C | 5,436 | (1) | (1) | Common Stock | 5,436 | (1) | 0 | I | TCV VII (A), L.P.(2)(6) | |||
| Series B Preferred Stock | (1) | 07/22/2015 | C | 91 | (1) | (1) | Common Stock | 91 | (1) | 0 | I | TCV Member Fund, L.P.(2)(8) | |||
| Series C Preferred Stock | (4) | 07/22/2015 | C | 4,498,677 | (4) | (4) | Common Stock | 4,498,677 | (4) | 0 | I | TCV VII, L.P.(2)(3) | |||
| Series C Preferred Stock | (4) | 07/22/2015 | C | 2,336,270 | (4) | (4) | Common Stock | 2,336,270 | (4) | 0 | I | TCV VII (A), L.P.(2)(6) | |||
| Series C Preferred Stock | (4) | 07/22/2015 | C | 38,850 | (4) | (4) | Common Stock | 38,850 | (4) | 0 | I | TCV Member Fund, L.P.(2)(8) | |||
| Series D Preferred Stock | (10) | 07/22/2015 | C | 849,507 | (10) | (10) | Common Stock | 849,507 | (10) | 0 | I | TCV VII, L.P.(2)(3) | |||
| Series D Preferred Stock | (10) | 07/22/2015 | C | 441,169 | (10) | (10) | Common Stock | 441,169 | (10) | 0 | I | TCV VII (A), L.P.(2)(6) | |||
| Series D Preferred Stock | (10) | 07/22/2015 | C | 7,576 | (10) | (10) | Common Stock | 7,576 | (10) | 0 | I | TCV Member Fund, L.P.(2)(8) | |||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
| Explanation of Responses: |
| 1. The Series B Preferred Stock automatically converted into the same number of shares of Common Stock upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date. |
| 2. This Form 4 is filed by more than one Reporting Person and is a joint filing with the Form 4 filed by Jay C. Hoag, Christopher P. Marshall, Richard H. Kimball, John L. Drew, Jon Q. Reynolds, Jr., Robert W. Trudeau, John C. Rosenberg, David L. Yuan, TCV VII, L.P. and TCV VII (A), L.P. on July 24, 2015 and relates to the same transactions. |
| 3. These securities are directly held by TCV VII, L.P. Timothy P. McAdam, Jay C. Hoag, Christopher P. Marshall, Jon Q. Reynolds, Jr., Richard H. Kimball, John L. Drew, Robert W. Trudeau, John C. Rosenberg and David L. Yuan (collectively, the "TCM VII Directors") are Class A Directors of Technology Crossover Management VII, Ltd. ("Management VII") and limited partners of Technology Crossover Management VII, L.P. ("TCM VII"). Management VII is the general partner of TCM VII, which is the general partner of TCV VII, L.P. The TCM VII Directors, Management VII and TCM VII may be deemed to beneficially own the securities held by TCV VII, L.P., but each of the TCM VII Directors, Management VII and TCM VII disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. |
| 4. The Series C Preferred Stock automatically converted into the same number of shares of Common Stock upon the closing of the Issuer's initial public offering. The Series C Preferred Stock had no expiration date. |
| 5. Reflects 849,507 shares that were received in connection with the automatic conversion of the Series D Preferred Stock into the same number of shares of Common Stock upon the closing of the Issuer's initial public offering and 613,450 additional shares that were received by TCV VII, L.P. upon the closing of the Issuer's initial public offering in connection with the conversion of shares of the Issuer's Series D Preferred Stock into Common Stock pursuant to the provisions of the Issuer's certificate of incorporation then in effect. |
| 6. These securities are directly held by TCV VII (A), L.P. The TCM VII Directors are Class A Directors of Management VII and limited partners of TCM VII. Management VII is the general partner of TCM VII, which is the general partner of TCV VII (A), L.P. The TCM VII Directors, Management VII and TCM VII may be deemed to beneficially own the securities held by TCV VII (A), L.P., but each of the TCM VII Directors, Management VII and TCM VII disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. |
| 7. Reflects 441,169 shares that were received in connection with the automatic conversion of the Series D Preferred Stock into the same number of shares of Common Stock upon the closing of the Issuer's initial public offering and 318,579 additional shares that were received by TCV VII (A), L.P. upon the closing of the Issuer's initial public offering in connection with the conversion of shares of the Issuer's Series D Preferred Stock into Common Stock pursuant to the provisions of the Issuer's certificate of incorporation then in effect. |
| 8. These securities are directly held by TCV Member Fund, L.P. ("TCV MF"). The TCM VII Directors are Class A Directors of Management VII, which is a general partner of TCV MF, and limited partners of TCV MF. The TCM VII Directors and Management VII may be deemed to beneficially own the securities held by TCV MF, but the TCM VII Directors and Management VII each disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. |
| 9. Reflects 7,576 shares that were received in connection with the automatic conversion of the Series D Preferred Stock into the same number of shares of Common Stock upon the closing of the Issuer's initial public offering and 5,470 additional shares that were received by TCV MF upon the closing of the Issuer's initial public offering in connection with the conversion of shares of the Issuer's Series D Preferred Stock into Common Stock pursuant to the provisions of the Issuer's certificate of incorporation then in effect. |
| 10. The Series D Preferred Stock automatically converted into the same number of shares of Common Stock upon the closing of the Issuer's initial public offering. The Series D Preferred Stock had no expiration date. |
| Remarks: |
| Frederic D. Fenton, Authorized Signatory for Timothy P. McAdam | 07/24/2015 | |
| Frederic D. Fenton, Authorized Signatory for TCV Member Fund, L.P. | 07/24/2015 | |
| Frederic D. Fenton, Authorized Signatory for Technology Crossover Management VII, L.P. | 07/24/2015 | |
| Frederic D. Fenton, Authorized Signatory for Technology Crossover Management VII, Ltd. | 07/24/2015 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
